Journavx Tablet, Film Coated
Product Images NDC 51167-548

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Journavx (NDC 51167-548). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vertex Pharmaceuticals Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Journavx 01)

Chemical structure diagram of suzetrigine, the active ingredient in JOURNAVX 50 mg oral film-coated tablets. The diagram shows molecular bonds including trifluoromethyl, methoxy, and amide groups.*

FDA Label Image

Figure 1 (Journavx 02)

A line graph comparing mean NPRS (Numeric Pain Rating Scale) scores over 48 hours for three groups: Placebo, HB/APAP, and JOURNAVX. The x-axis represents time in hours, and the y-axis shows mean NPRS values, illustrating differences in pain score trends among the treatment groups.*

FDA Label Image

Figure 2 (Journavx 03)

Line chart comparing mean NPRS (Numeric Pain Rating Scale) scores over time (hours) for three groups: Placebo, HB/APAP, and JOURNAVX. The x-axis is labeled Time (hours) from 0 to 48, and the y-axis shows Mean NPRS scores from 0 to 10. The chart tracks pain levels measured at multiple time points for each treatment group.*

FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

JOURNAVX (Suzetrigine) tablets 50 mg film-coated oral tablets label. The package contains 30 tablets. Label shows dosing and storage instructions and the manufacturer Vertex Pharmaceuticals Incorporated. Includes NDC 51167-548-30 with barcode and lot, expiration, and serial number fields.*

FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

JOURNAVX (suzetrigine) tablets 50 mg film-coated oral tablets label showing a 100-tablet count. The label includes dosage strength, prescription status, manufacturer Vertex Pharmaceuticals Incorporated, barcode, and storage instructions.*

FDA Label Image

Principal Display Panel (50 mg Tablet Blister Pack Carton)

JOURNAVX 50 mg tablets packaging label showing a film-coated oral tablet product labeled for institutional use only. The label indicates 100 tablets per unit dose package and names suzetrigine as the active ingredient. Manufactured by Vertex Pharmaceuticals Incorporated, the carton includes NDC 51167-548 and features company logos and a barcode.*

FDA Label Image

Principal Display Panel (50 mg Tablet Blister Pack Carton)

Carton label for JOURNAVX (suzetrigine) tablets, 50 mg per tablet, an oral film-coated tablet by Vertex Pharmaceuticals Incorporated. The label indicates the product is a professional sample not for sale, with package content of 5 blister wallets containing 5 tablets each. It includes storage instructions and a QR code for ordering samples.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.